sprite-preloader
Freitag, 18.04.2014 Börsentäglich über 12.000 News von 475 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 899527 ISIN: US0153511094 Ticker-Symbol: AXP 
Aktie:
Branche
Pharma
Aktienmarkt
NASDAQ-100
S&P 500
NASDAQ Biotech
1-Jahres-Chart
ALEXION PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
ALEXION PHARMACEUTICALS INC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
108,34
108,55
17.04.

Aktuelle News zu ALEXION PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
ALEXION PHARMACEUTICALS Aktie jetzt ab 5 Dollar handeln!

--> Artikel lesen
DoALEXION PHARMACEUTICALS INC - 8-K, Current Report3

--> Artikel lesen
DoLook for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 2.50% Rise1

--> Artikel lesen
MiAlexion Pharmaceuticals Bullish Moving Average Crossover Alert1

--> Artikel lesen
MoTechnical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences22
LONDON, April 14, 2014 /PRNewswire/ -- On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89% to 16,026.75, and the S&P 500...
--> Artikel lesen
MoAcquisitions, Director Appointments, Collaborations, New Product Launches, and Earnings Guidance Revisions - Analyst Notes on Questcor, Regeneron, Lilly, Medtronic and Alexion12
NEW YORK, April 14, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)...
--> Artikel lesen
11.04.Why Alexion Pharmaceuticals, Gilead Sciences, and Monster Beverage Corporation Are Today's 3 Worst S39

--> Artikel lesen
09.04.Alexion Pharmaceuticals Crosses Above its 10-day MA6

--> Artikel lesen
08.04.The Zacks Analyst Blog Highlights: Facebook, Tesla Motors, Amazon.com, Netflix and Alexion Pharmaceuticals17
CHICAGO, April 8, 2014 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
--> Artikel lesen
07.04.BioMed Realty Invests In Life Science Research Facilities Leased To Yale University, Yale-New Haven Hospital And Alexion Pharmaceuticals6
SAN DIEGO, April 7, 2014 /PRNewswire/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced the investment in two properties, 300 George Street and 100 College Street, in the growing life science...
--> Artikel lesen
04.04.Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines20
NEW YORK, April 4, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Medtronic, Inc. (NYSE: MDT), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), DaVita, Inc. (NYSE:...
--> Artikel lesen
04.04.Alexion's €75m investment to create 200 new jobs in Dublin4

--> Artikel lesen
03.04.Alexion Pharma International Trading of US to add 200 jobs in West Dublin-

--> Artikel lesen
03.04.Pharmaceutical firm Alexion to create 200 jobs in Blanchardstown1

--> Artikel lesen
03.04.Alexion expansion to create 200 jobs in Dublin-

--> Artikel lesen
03.04.Biopharma group Alexion to hire 200 at new Dublin plant1

--> Artikel lesen
02.04.SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 2.11% Gain3

--> Artikel lesen
27.03.Alexion Pharmaceuticals Price Target Increased to $171.00 by Analysts at Credit Suisse9

--> Artikel lesen
26.03.The Zacks Analyst Blog Highlights: IShares NASDAQ Biotechnology ETF, Gilead, Alexion Pharmaceuticals, Amgen and Myriad Genetics72
CHICAGO, March 26, 2014 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
--> Artikel lesen
26.03.Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic25
NEW YORK, March 26, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Actavis plc Ordinary...
--> Artikel lesen
25.03.Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences37
LONDON, March 25, 2014 /PRNewswire/ -- On Monday, March 24, 2014, the NASDAQ Composite ended at 4,226.39, down 1.18%, the Dow Jones Industrial Average declined 0.16% to 16,276.69, and the S&P 500...
--> Artikel lesen
Seite:  Weiter >>
220 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
ALEXION PHARMACEUTICALS INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
GILEAD SCIENCES50,94+1,88 %Ausverkauf in den USA: 3D Systems, Amazon, Gilead und Netflix brechen ein
Die Stabilisierung am US-Aktienmarkt war nur von kurzer Dauer. Nach zwei freundlicheren Tagen rauschten die wichtigsten Indizes gestern wieder in die Tiefe. Dabei gerieten erneut vor allem Hightech-...
--> Artikel lesen
NOVO NORDISK31,94+1,98 %Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes
BAGSVÆRD, Denmark, March 28, 2014 /PRNewswire/ --  Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge....
--> Artikel lesen
CELGENE103,53+2,35 %Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA
NEW YORK, April 14, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA), Chelsea Therapeutics...
--> Artikel lesen
STADA ARZNEIMITTEL29,13+0,15 %STADA-Aktie: Leerverkäufer Marshall Wace schießt weiter scharf - Aktiennews
Bad Vilbel - Leerverkäufer Marshall Wace baut Netto-Leerverkaufsposition in Aktien der STADA Arzneimittel AG weiter aus Die Leerverkäufer des Hedgefonds Marshall Wace bauen ihr Short-Engagement in den...
--> Artikel lesen
BRISTOL-MYERS SQUIBB35,361+0,15 %Bristol-Myers Submits NDA For Combination Tablet Of Atazanavir With Cobicistat
FOSTER CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) announced it has submitted a new drug application (NDA) to the U.S. FDA for a fixed-dose combination of atazanavir sulfate, a protease...
--> Artikel lesen
Lade...